BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 28438502)

  • 1. US drug shortages might have led to more patient deaths.
    Furlow B
    Lancet Respir Med; 2017 Jun; 5(6):469. PubMed ID: 28438502
    [No Abstract]   [Full Text] [Related]  

  • 2. Norepinephrine Shortage Led to Increased Deaths from Septic Shock.
    Stockwell S
    Am J Nurs; 2017 Jul; 117(7):15. PubMed ID: 28644271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock.
    Vail E; Gershengorn HB; Hua M; Walkey AJ; Rubenfeld G; Wunsch H
    JAMA; 2017 Apr; 317(14):1433-1442. PubMed ID: 28322415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
    Russell JA; Walley KR; Gordon AC; Cooper DJ; Hébert PC; Singer J; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ;
    Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Plasma Angiopoietin-2 Levels Are Associated With Fluid Overload, Organ Dysfunction, and Mortality in Human Septic Shock.
    Fisher J; Douglas JJ; Linder A; Boyd JH; Walley KR; Russell JA
    Crit Care Med; 2016 Nov; 44(11):2018-2027. PubMed ID: 27441903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the addition of vasopressin to norepinephrine beneficial for the treatment of septic shock?
    Sandifer JP; Jones AE
    Ann Emerg Med; 2013 Nov; 62(5):534-535. PubMed ID: 23683544
    [No Abstract]   [Full Text] [Related]  

  • 7. Deaths from Clostridium sordellii after medical abortion.
    Zane SB; Berg CJ
    N Engl J Med; 2006 Apr; 354(15):1645-7; author reply 1645-7. PubMed ID: 16615187
    [No Abstract]   [Full Text] [Related]  

  • 8. Septic shock and the use of norepinephrine in an intermediate care unit: Mortality and adverse events.
    Hallengren M; Åstrand P; Eksborg S; Barle H; Frostell C
    PLoS One; 2017; 12(8):e0183073. PubMed ID: 28837628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
    Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
    Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin in septic shock.
    Landry DW; Oliver JA
    N Engl J Med; 2008 Jun; 358(25):2736-7; author reply 2737-8. PubMed ID: 18572443
    [No Abstract]   [Full Text] [Related]  

  • 12. Septic shock--vasopressin, norepinephrine, and urgency.
    Parrillo JE
    N Engl J Med; 2008 Feb; 358(9):954-6. PubMed ID: 18305271
    [No Abstract]   [Full Text] [Related]  

  • 13. Terlipressin for norepinephrine-resistant septic shock.
    O'Brien A; Clapp L; Singer M
    Lancet; 2002 Apr; 359(9313):1209-10. PubMed ID: 11955542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical management for patients admitted to a critical care unit with severe sepsis or septic shock.
    Cheung WK; Chau LS; Mak II; Wong MY; Wong SL; Tiwari AF
    Intensive Crit Care Nurs; 2015 Dec; 31(6):359-65. PubMed ID: 26292920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terlipressin in the treatment of late phase catecholamine-resistant septic shock.
    Svoboda P; Scheer P; Kantorová I; Doubek J; Dudra J; Radvan M; Radvanova J
    Hepatogastroenterology; 2012 Jun; 59(116):1043-7. PubMed ID: 22580654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of norepinephrine versus dopamine for septic shock: a meta analysis].
    Zhou FH; Song Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Aug; 25(8):449-54. PubMed ID: 24021037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and beneficial hemodynamic effects of activated protein C in septic shock patients.
    Monnet X; Lamia B; Anguel N; Richard C; Bonmarchand G; Teboul JL
    Intensive Care Med; 2005 Nov; 31(11):1573-6. PubMed ID: 16175347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. It's not cherry-picking, it's bridging the gap.
    de Carvalho WB; Machado Fonseca MC
    Pediatr Crit Care Med; 2010 Mar; 11(2):304-5. PubMed ID: 20216178
    [No Abstract]   [Full Text] [Related]  

  • 19. Refractory septic shock: efficacy and safety of very high doses of norepinephrine.
    Katsaragakis S; Kapralou A; Theodorou D; Markogiannakis H; Larentzakis A; Stamou KM; Drimousis P; Bramis I
    Methods Find Exp Clin Pharmacol; 2006 Jun; 28(5):307-13. PubMed ID: 16845448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose vasopressin is not superior to norepinephrine in septic shock.
    Klinzing S; Simon M; Reinhart K; Bredle DL; Meier-Hellmann A
    Crit Care Med; 2003 Nov; 31(11):2646-50. PubMed ID: 14605537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.